<DOC>
	<DOCNO>NCT02520817</DOCNO>
	<brief_summary>Minimal hepatic encephalopathy ( MHE ) far-reaching impact quality ability function daily life may progress overt Hepatic Encephalopathy . Patients MHE miss clinical follow exposure work accident . The aim present study assess effect oral supplementation antioxidant zinc gluconate Versus Lactulose inTruck driver cirrhotic patient MHE .</brief_summary>
	<brief_title>Antioxidants Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers ; Pilot Study</brief_title>
	<detailed_description>The aim present study assess effect oral supplementation antioxidant zinc gluconate patient MHE . Zinc , may consider cofactor urea cycle enzyme , deficient cirrhotic patient ; especially associate , malnutrition encephalopathy . Zinc essential synthesis coenzyme mediate biogenic amine synthesis metabolism . Data study sustain , synergistic combine effect systemic oxidative stress , ammonia implicate pathogenesis hepatic encephalopathy , present study design assess effect oral supplementation antioxidant zinc gluconate cirrhotic Truck driver patient MHE . A prospective randomize control study compare effect zinc antioxidant supplementation plus lactulose MHE versus lactulose alone . Patients diagnose MHE randomly assign either receive zinc antioxidant plus lactulose ( group A ) lactulose alone ( group B , control ) . Patients group A receive 175 mg zinc gluconate , 50000 iu vitamin A , 500 mg vitamin C 100 mg vitamin E daily plus lactulose ( 30-60 ml 2 3 divided dos ) , patient group B receive 30-60 ml lactulose 2 3 divided dos patient pass 2-3 semi soft stool per day . The therapy take daily 3 month patient discontinue study drug reason ( e.g . non compliance ) . All patient follow every month treatment compliance development complication . The compliance therapy assure primarily ensure increase stool frequency change softer consistency count number bottle lactulose consume . None study , patient specifically treat therapy MHE within study period ( e.g . rifaximin ) .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Truck driver liver cirrhosis minimal hepatic encephalopathy . Exclusion criterion : Overt hepatic encephalopathy . Sensory motor deficit ; neurological cause impaired cognition Electrolyte imbalance ( serum sodium level &lt; 125 mmol/L ; serum calcium level &gt; 10 mg per /DL potassium level &lt; 2.5 mmol/L ) Ongoing systemic illness , intercurrent infection active spontaneous bacterial peritonitis . Recent history ( &lt; 6 week ) alcohol intake . Patients drug affect psychometric performance . Recent ( &lt; 6 week ) intake antibiotic gastrointestinal bleeding , history shunt operation trans jugular intrahepatic portosystemic shunt portal hypertension . Chronic renal impairment ( creatinine level &gt; 2.0 mg per/ DL . Patients color blindness , mature cataract diabetic retinopathy , Hepatocellular carcinoma , comorbidities congestive heart failure pulmonary disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Antioxidants</keyword>
	<keyword>Zinc</keyword>
	<keyword>Truck driver</keyword>
</DOC>